Response to "Comment on 'Dementia prevention: The potential long-term cost-effectiveness of the FINGER prevention program'"
Alzheimers Dement
.
2023 Oct;19(10):4760-4763.
doi: 10.1002/alz.13044.
Epub 2023 May 2.
Authors
Anders Wimo
1
,
Ron Handels
1
2
3
,
Riitta Antikainen
4
,
Maria Eriksdotter
5
6
,
Linus Jönsson
1
,
Martin Knapp
7
,
Jenni Kulmala
8
9
10
,
Tiina Laatikainen
11
12
,
Jenni Lehtisalo
10
13
,
Markku Peltonen
10
14
,
Anders Sköldunger
1
,
Hilkka Soininen
15
,
Alina Solomon
15
16
,
Timo Strandberg T
17
18
19
,
Jaakko Tuomilehto
18
20
21
22
,
Tiia Ngandu
10
16
,
Miia Kivipelto
6
12
16
23
Affiliations
1
Department of NVS, Centre of Alzheimer research, division of neurogeriatrics, Karolinska Institutet, Stockholm, Sweden.
2
Deperatment of Psychiatry and Neuropsychology, Maastricht University.
3
Alzheimer Centre Limburg, School for Mental Health and Neurosciences, Maastricht, The Netherlands.
4
Center for Life Course Health Research/Geriatrics, University of Oulu, Medical Research Center, Oulu University Hospital, Oulu, Finland.
5
Department of NVS, Centre of Alzheimer research, division of clinical geriatrics Karolinska Institutet, Stockholm, Sweden.
6
Theme Inflammation and Aging, Karolinska university hospital, Stockholm, Sweden.
7
Care Policy and Evaluation Centre, Department of Health Policy, London School of Economics and Political Science, London, UK.
8
Faculty of Social Sciences (Health Sciences) and Gerontology Research Center (GEREC), Tampere University, Finland.
9
Division of Clinical Geriatrics, Center for Alzheimer Research, NVS, Karolinska Institutet, Stockholm, Sweden.
10
Population Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
11
Department of Public Health and Welfate, Finnish Institute for Health and Welfare, Helsinki, Finland.
12
Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
13
Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
14
Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Sweden.
15
Institute of Clinical Medicine, neurology, University of Eastern Finland, Kuopio, Finland.
16
Division of Clinical Geriatrics, NVS, Karolinska Institutet, Stockholm, Sweden.
17
Public Health Promotion Unit, National Institute for Health and Welfare, Helsinki, Finland.
18
Department of Public Health, University of Helsinki, Helsinki, Finland.
19
National School of Public Health, Madrid, Spain.
20
Population Health Promotion Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
21
South Ostrobothnia Central Hospital, Seinäjoki, Finland.
22
Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia.
23
Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK.
PMID:
37130291
DOI:
10.1002/alz.13044
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Cost-Benefit Analysis
Cost-Effectiveness Analysis*
Dementia* / prevention & control
Humans